Approximately 2 out of 7 patients expressed IFN-γ and granzyme B. The administration of mucin 1-peptide-pulsed DCs was well tolerated and able to induce a mucin 1-specific immune response in advanced PC patients. This evidence concerns the gene MUC1 and pachyonychia congenita.